MSR113 Inferring the Proportion of Durable Responders to Targeted Oncology Therapies in Combination Regimens Using Bayesian Parametric Mixture Survival Models
Abstract
Authors
D. Sharpe
D. Sharpe
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now